Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2015 | FY2016 | FY2017 | FY2018 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75.0M | $82.4M | $90.6M | $124M | $150M | $230M | $239M | $322M | $314M | $239M |
| Revenue growth | — | 9.9% | 9.9% | 36.8% | 21.2% | 53.5% | 3.9% | 34.7% | -2.6% | -23.7% |
| Gross profit | $48.8M | $58.4M | $64.3M | $91.5M | $112M | $179M | $223M | $253M | $240M | $182M |
| Gross margin | 65.1% | 70.8% | 70.9% | 73.8% | 74.5% | 77.5% | 93.3% | 78.4% | 76.3% | 76.2% |
| Operating income | -$8.03M | -$12.7M | -$3.63M | $6.59M | $11.9M | $33.3M | $43.8M | $28.1M | -$12.6M | -$91.7M |
| Operating margin | -10.7% | -15.4% | -4.0% | 5.3% | 7.9% | 14.5% | 18.3% | 8.7% | -4.0% | -38.3% |
| Net income | -$8.39M | -$12.1M | -$2.14M | $4.97M | $14.0M | $27.5M | $39.7M | $21.3M | -$20.2M | -$80.4M |
| Net margin | -11.2% | -14.7% | -2.4% | 4.0% | 9.4% | 11.9% | 16.6% | 6.6% | -6.4% | -33.6% |
| EPS (diluted) | -$0.22 | -$0.30 | -$0.05 | $0.11 | $0.30 | $0.56 | $0.80 | $0.43 | -$0.41 | -$1.62 |
| Fiscal year | FY2015 | FY2016 | FY2017 | FY2018 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$7.95M | $1.05M | $2.85M | $12.8M | $25.8M | $44.0M | $35.7M | $14.6M | $15.7M | -$34.2M |
| Capital expenditures | $4.05M | $3.21M | $1.05M | $2.25M | $10.1M | $13.6M | $18.1M | $18.2M | $23.4M | $5.82M |
| Free cash flow | -$12.0M | -$2.16M | $1.81M | $10.5M | $15.7M | $30.3M | $17.6M | -$3.59M | -$7.67M | -$40.0M |
| Share buybacks | — | — | — | — | — | — | — | — | — | $6.46M |
| Fiscal year | FY2015 | FY2016 | FY2017 | FY2018 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $13.0M | $14.0M | $18.5M | $104M | $120M | $200M | $86.5M | $183M | $144M | $153M |
| Total assets | $58.9M | $65.5M | $67.9M | $167M | $208M | $346M | $419M | $489M | $510M | $452M |
| Total liabilities | $21.8M | $27.6M | $25.0M | $34.9M | $47.6M | $87.2M | $82.7M | $103M | $112M | $107M |
| Shareholders' equity | $37.1M | $37.9M | $42.9M | $132M | $160M | $262M | $336M | $386M | $397M | $344M |
| Retained earnings | -$140M | -$159M | -$161M | -$156M | -$142M | -$111M | -$68.7M | -$47.4M | -$67.6M | -$148M |
| Shares (wtd avg diluted) | 38.1M | 40.3M | 41.0M | 45.3M | 46.9M | 49.5M | 49.4M | 49.4M | 49.1M | 49.6M |
Every figure is extracted from STAAR SURGICAL CO’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.